Hepatitis E - epidemiology and clinical course in the largest cohort in the Czech Republic

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F22%3A00076453" target="_blank" >RIV/65269705:_____/22:00076453 - isvavai.cz</a>
Alternative codes found
RIV/00209775:_____/22:N0000020 RIV/00216224:14110/22:00126979 RIV/00027162:_____/22:N0000254
Result on the web
<a href="https://www.archivesofmedicalscience.com/pdf-152338-78030?filename=Hepatitis%20E%20_.pdf" target="_blank" >https://www.archivesofmedicalscience.com/pdf-152338-78030?filename=Hepatitis%20E%20_.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5114/aoms/152338" target="_blank" >10.5114/aoms/152338</a>

Result language
angličtina
Original language name
Hepatitis E - epidemiology and clinical course in the largest cohort in the Czech Republic
Original language description
Introduction: The majority of hepatitis E (HE) reports come from WesternEurope. The aim of the study was to describe the typical epidemiological andclinical characteristics of HE in the Czech Republic.Methods: A retrospective analysis of 173 patients with HE.Results: At least 90% of cases were autochthonous (HEV-3 genotype). Seventeen patients were treated with ribavirin. Five underwent liver transplantsbecause of fulminant HE. We noted neurological symptomatology in 9 cases.Six patients developed chronic HE.Conclusions: There is a possibility of severe health complications caused bythe hepatitis E virus in the Czech Republic.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30218 - General and internal medicine

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)